|
🐢
|
Cytomegalovirus in transplantation – challenging the status quo
9 auth.
J. Fishman,
V. Emery,
R. Freeman,
M. Pascual,
L. Rostaing,
H. Schlitt,
...
D. Sgarabotto,
J. Torre-Cisneros,
M. Uknis
|
8 |
2007 |
8
🐢
|
|
🐜
|
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
11 auth.
G. Papanicolaou,
F. Silveira,
A. Langston,
Marcus R. Pereira,
R. Avery,
M. Uknis,
...
A. Wijatyk,
Jingyang J. Wu,
M. Boeckh,
F. Marty,
S. Villano
|
7 |
2018 |
7
🐜
|
|
🐢
|
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double‐Blind, Multicenter Controlled Trial
15 auth.
D. Winston,
F. Saliba,
E. Blumberg,
M. Abouljoud,
J. Garcia-Diaz,
J. Goss,
L. Clough,
R. Avery,
A. Limaye,
B. Ericzon,
...
M. Navasa,
R. Troisi,
Hongzi Chen,
S. Villano,
M. Uknis
|
6 |
2012 |
6
🐢
|
|
🐜
|
Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.
10 auth.
J. Maertens,
C. Cordonnier,
P. Jaksch,
X. Poiré,
M. Uknis,
Jingyang J. Wu,
...
A. Wijatyk,
F. Saliba,
O. Witzke,
S. Villano
|
6 |
2019 |
6
🐜
|
|
🐬
|
Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
A. Humar,
M. Uknis,
C. Carlone-Jambor,
R. Gruessner,
D. Dunn,
A. Matas
|
6 |
1999 |
6
🐬
|
|
🐬
|
Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis.
H. Klaerner,
M. Uknis,
R. Acton,
P. Dahlberg,
C. Carlone-Jambor,
D. Dunn
|
5 |
1997 |
5
🐬
|
|
🐢
|
Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
7 auth.
W. Lumry,
M. Manning,
D. Hurewitz,
M. Davis-Lorton,
D. Fitts,
I. Kalfus,
...
M. Uknis
|
5 |
2013 |
5
🐢
|
|
🐜
|
Oral Ganciclovir Versus Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Recipients of Kidney and Pancreas Transplants
8 auth.
F. Weng,
A. Patel,
R. Wanchoo,
Y. Brahmbhatt,
K. Ribeiro,
M. Uknis,
...
S. Mulgaonkar,
Scott Mathis
|
5 |
2007 |
5
🐜
|
|
🐜
|
Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.
7 auth.
R. Acton,
P. Dahlberg,
M. Uknis,
H. Klaerner,
G. Fink,
J. Norman,
...
D. Dunn
|
5 |
1996 |
5
🐜
|
